Transmedics Group Inc (TMDX) Stock Price, Quote & News

Company Profile

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of s...

Industry: Medical Devices

Sector: Healthcare

Phone: 978 552 0900

Website: www.transmedics.com

Address:

200 Minuteman Road, Suite 302, Andover, United States

Pepper22 Aug. 25 at 6:00 PM

$TMDX what a piece of crap.

0 · Reply

NeverPop Aug. 25 at 4:58 PM

$TMDX 114 and 106 are next lines in the sand?

0 · Reply

Wallstfan Aug. 25 at 3:56 PM

$TMDX almost at that $114 buy range again.

0 · Reply

JarvisFlow Aug. 25 at 2:52 PM

Needham updates rating for TransMedics Group ( $TMDX ) to Hold.

1 · Reply

Lambster2 Aug. 25 at 1:43 PM

$TMDX TransMedics (NASDAQ: TMDX) Buy (1) ESG Score: 61/100 Price Target: $170.00 Industry Validation of Organ Preservation Tech: Terumo’s $1.5B OrganOx Purchase THE TD COWEN INSIGHT Terumo’s $1.5B OrganOx acquisition validates the strategic value of organ preservation technology. While OrganOx could gain strength under Terumo's roof, we believe TransMedics’ OCS platform, NOP, and aviation/logistics combo offering remains unmatched and best positioned to gain share, expand DCD/DBD liver donor organ utilization and drive liver transplant growth. Reiterate Buy.

1 · Reply

mainman Aug. 25 at 11:20 AM

$TMDX Does Terumo have jets ? Are they expanding geographically like TMDX ?

0 · Reply

buylowandwait Aug. 25 at 1:47 AM

$TMDX OrganOX was just acquired by Terumo for 1.5B https://www.globenewswire.com/news-release/2025/08/25/3138180/0/en/Terumo-to-acquire-OrganOx-Limited-a-leading-innovator-in-organ-preservation-devices-marking-strategic-entry-into-the-organ-transplantation-related-sector.html OrganOX 2024 revenue was roughly 75M. To find out value for TMDX with this acquisition in mind, TMDX 2024 revenue 440M, if we apply the same Market Cap/Revenue multiple, TMDX would be valued at 440/75*1.5 = 8.8B. Acquisition price for TMDX based on the simple comparison would be 264/share.

1 · Reply

Halo202 Aug. 24 at 11:07 PM

$TMDX $123+ this week

0 · Reply

TriGuy8542 Aug. 24 at 4:28 PM

$TMDX so the Waleed gap is gone. What’s next? Chart is seems messy. What do the technicians think?

0 · Reply

DavidMacph1 Aug. 24 at 2:48 PM

$TMDX is one worth watching closely here; this one can continue grinding much higher here. There is a lot of potential in this name. This one is forming a flag here after a big move up. Bullish over the 133 level.

0 · Reply

TransMedics: CEO Is Buying Shares Ahead Of A Potentially Concerning Q3

Aug 12, 2025, 8:00 PM EDT - 12 days ago

Technical Tuesday: SPX All-Time High, OKLO Bull Flags & TMDX Bullish SMA

OKLO

Aug 4, 2025, 8:00 AM EDT - 21 days ago

TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial

Aug 1, 2025, 4:05 PM EDT - 23 days ago

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Aug 1, 2025, 6:25 AM EDT - 24 days ago

TransMedics: Continued Strength Suggests Further Upside

Jul 31, 2025, 12:28 AM EDT - 25 days ago

TransMedics Group, Inc. (TMDX) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 4:05 PM EDT - 25 days ago

TransMedics Reports Second Quarter 2025 Financial Results

Jul 29, 2025, 4:05 PM EDT - 26 days ago

TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 25, 2025, 11:57 AM EDT - 4 weeks ago

Why TransMedics Remains A Buy Into 2026

Jul 23, 2025, 4:17 PM EDT - 4 weeks ago

This Company Transports Donated Organs. Its Stock Has Had a Roller-Coaster Ride.

Jul 16, 2025, 4:05 PM EDT - 5 weeks ago

TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025

Jul 14, 2025, 12:27 AM EDT - 6 weeks ago

TransMedics: Q2 Analyst Estimates Will Fall Short

Jun 23, 2025, 10:00 AM EDT - 2 months ago

TransMedics' Turnaround: The Organ Transplant Leader Is Still A Buy

Jun 17, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect

Jun 15, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out

Jun 12, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation

Jun 10, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation

Jun 8, 2025, 10:00 AM EDT - 2 months ago

TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 5, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect

Jun 1, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation

May 29, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Investors to Reach Out

May 27, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out

May 25, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect

May 22, 2025, 10:00 AM EDT - 3 months ago

TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 21, 2025, 4:54 AM EDT - 3 months ago

TransMedics: Extremely Undervalued And Extremely Innovative

May 20, 2025, 4:05 PM EDT - 3 months ago

TransMedics to Present at Upcoming June Investor Conferences

May 13, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Shareholders to Learn More About the Investigation

May 11, 2025, 10:00 AM EDT - 3 months ago

TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

May 9, 2025, 9:48 AM EDT - 3 months ago

TransMedics: Exceptional Q1 Undermines The Short Narrative

May 8, 2025, 10:40 PM EDT - 3 months ago

TransMedics Group, Inc. (TMDX) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 3 months ago

TransMedics Reports First Quarter 2025 Financial Results

Apr 24, 2025, 4:05 PM EDT - 4 months ago

TransMedics to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 23, 2025, 4:23 AM EDT - 4 months ago

TransMedics: Get Some Exposure Despite Market Concerns

Apr 22, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Stockholders to Learn More About the Investigation

Apr 11, 2025, 7:43 AM EDT - 4 months ago

TMDX STOCK FRAUD: Did TransMedics Group Commit Securities Fraud? Investors are Notified to Contact BFA Law by the April 15 Court Deadline (NASDAQ:TMDX)

Apr 11, 2025, 2:06 AM EDT - 4 months ago

DEADLINE NEXT WEEK: Berger Montague Advises TransMedics (NASDAQ: TMDX) Investors to Contact the Firm Before April 15, 2025

Apr 10, 2025, 7:00 PM EDT - 4 months ago

Investor Reminder (TMDX): Kessler Topaz Meltzer & Check, LLP Reminds TransMedics Group, Inc. Investors of April 15, 2025 Deadline

Apr 10, 2025, 3:38 PM EDT - 4 months ago

TMDX STOCK NOTICE: TransMedics Group is being Sued for Fraud – Investors with Losses are Reminded to Contact BFA Law by April 15 Deadline

Apr 10, 2025, 10:42 AM EDT - 4 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group

Pepper22 Aug. 25 at 6:00 PM

$TMDX what a piece of crap.

0 · Reply

NeverPop Aug. 25 at 4:58 PM

$TMDX 114 and 106 are next lines in the sand?

0 · Reply

Wallstfan Aug. 25 at 3:56 PM

$TMDX almost at that $114 buy range again.

0 · Reply

JarvisFlow Aug. 25 at 2:52 PM

Needham updates rating for TransMedics Group ( $TMDX ) to Hold.

1 · Reply

Lambster2 Aug. 25 at 1:43 PM

1 · Reply

mainman Aug. 25 at 11:20 AM

$TMDX Does Terumo have jets ? Are they expanding geographically like TMDX ?

0 · Reply

buylowandwait Aug. 25 at 1:47 AM

1 · Reply

Halo202 Aug. 24 at 11:07 PM

$TMDX $123+ this week

0 · Reply

TriGuy8542 Aug. 24 at 4:28 PM

$TMDX so the Waleed gap is gone. What’s next? Chart is seems messy. What do the technicians think?

0 · Reply

DavidMacph1 Aug. 24 at 2:48 PM

0 · Reply

Kgceltics Aug. 23 at 7:04 PM

$PRCT $TMDX tmdx owners yall like prct ? I own a lot of tmdx. Made a lot. But that one may be interesting. Not profitable. Trades at same price to sales now. Outside my wheelhouse but seems promising.

2 · Reply

LoRezTrader Aug. 23 at 12:45 PM

$TMDX on the BBC https://x.com/loreztrader/status/1959090368277782667?s=46

0 · Reply

mainman Aug. 23 at 3:47 AM

$TMDX I am a long term investor, if the fundamentals are solid today and a positive future appears on the in Q3 and even more in Q4 , be patient ….. did you listen to Waleed in the last earnings con all ? But , hold and relax , it’s is important not to make decisions based on the noise. It is a 4 billion company soon to worth much more , the world needs this technology, the platform, and the logistics solutions which only TMDX has . If you sell , you will regret . Patience and Perseverance will prevail.

1 · Reply

SonGoku Aug. 22 at 8:21 PM

I keep seeing more people talk about $TMDX

0 · Reply

PhatRam32 Aug. 22 at 6:29 PM

$TMDX bought more. It will have its day. Nothing bad about this company and has a wide moat.

0 · Reply

Lambster2 Aug. 22 at 6:23 PM

$TMDX Added today. Set and forget

1 · Reply

Pika_Capital Aug. 22 at 6:11 PM

$TMDX this is for all cry babies who think that stock should rocket when market is up 1.5 points. It's already killing s&p by a HUGE margin this year

0 · Reply

Pika_Capital Aug. 22 at 6:06 PM

$TMDX lmao lots of crying on here. This is definitely bullish sign

0 · Reply

PhatRam32 Aug. 22 at 5:45 PM

$RDDT same thing happening with $TMDX

1 · Reply

Pepper22 Aug. 22 at 5:34 PM

$TMDX I’m out. Better opportunities elsewhere

1 · Reply

PhatRam32 Aug. 22 at 5:14 PM

$TMDX this is unbelievable

0 · Reply

PhatRam32 Aug. 22 at 5:02 PM

$TMDX I sold $OSCR for this? Whoops

0 · Reply

Market Cap	4.09B
Revenue (ttm)	441.54M
Net Income (ttm)	35.46M
EPS (ttm)	N/A
PE Ratio	61.56
Forward PE	51.16
Profit Margin	8.03%
Debt to Equity Ratio	0.19

Volume	446,420
Avg Vol	1,063,858
Day's Range	N/A - N/A
Shares Out	34.09M
Stochastic %K	16%
Beta	2.09
Analysts	Strong Sell
Price Target	$142.28